Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Breakthrough technique could one day provide tailored repairs for people with brain injuries October 4, 2023 New guidelines set safer standards for dental pain relief February 6, 2024 Engineered TIMPs show promise in fighting glioblastoma invasion March 3, 2025
Breakthrough technique could one day provide tailored repairs for people with brain injuries October 4, 2023